Manning & Napier Advisors LLC Bristol Myers Squibb CO Transaction History
Manning & Napier Advisors LLC
- $8.1 Trillion
- Q1 2025
A detailed history of Manning & Napier Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 475,080 shares of BMY stock, worth $23.8 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
475,080
Previous 509,364
6.73%
Holding current value
$23.8 Million
Previous $28.8 Billion
0.57%
% of portfolio
0.36%
Previous 0.33%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,783Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.54 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.96 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.82 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.78 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.03 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...